Literature DB >> 18672084

Regulatory B and T cells in infections.

Laleh Majlessi1, Richard Lo-Man, Claude Leclerc.   

Abstract

The role of T and B lymphocytes, as antigen-specific effector immune cells playing an essential role in host defense against pathogens, is well recognized. Over the last decade, these lymphocytes have however also emerged as key regulatory components of the immune system, able to prevent various immunopathologies due to excessive inflammatory responses. These regulatory T (Treg) and B (Breg) cells, endowed with anti-inflammatory properties, operate via both antigen-specific and non-specific mechanisms and mainly develop during chronic infections. Here, we discuss the role of Treg and Breg lymphocytes in various infectious diseases, in experimental murine models and in human.

Entities:  

Mesh:

Year:  2008        PMID: 18672084     DOI: 10.1016/j.micinf.2008.07.017

Source DB:  PubMed          Journal:  Microbes Infect        ISSN: 1286-4579            Impact factor:   2.700


  17 in total

1.  Indication for a role of regulatory T cells for the advent of influenza A (H1N1)-related pneumonia.

Authors:  M Raftogiannis; A Antonopoulou; F Baziaka; A Spyridaki; P Koutoukas; T Tsaganos; A Savva; A Pistiki; M Georgitsi; E J Giamarellos-Bourboulis
Journal:  Clin Exp Immunol       Date:  2010-09       Impact factor: 4.330

Review 2.  The role of interleukin-15 in inflammation and immune responses to infection: implications for its therapeutic use.

Authors:  Pin-Yu Perera; Jack H Lichy; Thomas A Waldmann; Liyanage P Perera
Journal:  Microbes Infect       Date:  2011-10-25       Impact factor: 2.700

Review 3.  Procalcitonin in sepsis and systemic inflammation: a harmful biomarker and a therapeutic target.

Authors:  Kenneth L Becker; Richard Snider; Eric S Nylen
Journal:  Br J Pharmacol       Date:  2009-11-27       Impact factor: 8.739

4.  Regulatory B cell (B10 Cell) expansion during Listeria infection governs innate and cellular immune responses in mice.

Authors:  Mayuka Horikawa; Eric T Weimer; David J DiLillo; Guglielmo M Venturi; Rosanne Spolski; Warren J Leonard; Mark T Heise; Thomas F Tedder
Journal:  J Immunol       Date:  2012-12-28       Impact factor: 5.422

5.  Transforming growth factor beta and CD25 are important for controlling systemic dissemination following Yersinia enterocolitica infection of the gut.

Authors:  Youmin Zhong; Angelene Cantwell; Peter H Dube
Journal:  Infect Immun       Date:  2010-06-28       Impact factor: 3.441

6.  Genetic disruption of CD8+ Treg activity enhances the immune response to viral infection.

Authors:  Tobias A W Holderried; Philipp A Lang; Hye-Jung Kim; Harvey Cantor
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-09       Impact factor: 11.205

7.  Consumption of pasteurized human lysozyme transgenic goats' milk alters serum metabolite profile in young pigs.

Authors:  Dottie R Brundige; Elizabeth A Maga; Kirk C Klasing; James D Murray
Journal:  Transgenic Res       Date:  2009-10-22       Impact factor: 2.788

8.  Neutralization of interleukin-10 from CD14(+) monocytes enhances gamma interferon production in peripheral blood mononuclear cells from Mycobacterium avium subsp. paratuberculosis-infected goats.

Authors:  Kari R Lybeck; Anne K Storset; Ingrid Olsen
Journal:  Clin Vaccine Immunol       Date:  2009-05-06

9.  CD19+CD24hiCD38hi regulatory B cells: a potential immune predictive marker of severity and therapeutic responsiveness of hepatitis C.

Authors:  Qiannan Fang; Yanan Deng; Rongzhen Liang; Yongyu Mei; Zhaoxia Hu; Julie Wang; Jianbo Sun; Xiaohong Zhang; Joseph A Bellanti; Song Guo Zheng
Journal:  Am J Transl Res       Date:  2020-03-15       Impact factor: 4.060

10.  Effect of the novel influenza A (H1N1) virus in the human immune system.

Authors:  Evangelos J Giamarellos-Bourboulis; Maria Raftogiannis; Anastasia Antonopoulou; Fotini Baziaka; Pantelis Koutoukas; Athina Savva; Theodora Kanni; Marianna Georgitsi; Aikaterini Pistiki; Thomas Tsaganos; Nikolaos Pelekanos; Sofia Athanassia; Labrini Galani; Efthymia Giannitsioti; Dimitra Kavatha; Flora Kontopidou; Maria Mouktaroudi; Garyfallia Poulakou; Vissaria Sakka; Periklis Panagopoulos; Antonios Papadopoulos; Kyriaki Kanellakopoulou; Helen Giamarellou
Journal:  PLoS One       Date:  2009-12-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.